359 related articles for article (PubMed ID: 28260368)
1. [Research progress of treatment strategies for retinitis pigmentosa].
Qian TW; Xu X
Zhonghua Yan Ke Za Zhi; 2017 Feb; 53(2):148-153. PubMed ID: 28260368
[TBL] [Abstract][Full Text] [Related]
2. Non-syndromic retinitis pigmentosa.
Verbakel SK; van Huet RAC; Boon CJF; den Hollander AI; Collin RWJ; Klaver CCW; Hoyng CB; Roepman R; Klevering BJ
Prog Retin Eye Res; 2018 Sep; 66():157-186. PubMed ID: 29597005
[TBL] [Abstract][Full Text] [Related]
3. Large-scale phenotypic drug screen identifies neuroprotectants in zebrafish and mouse models of retinitis pigmentosa.
Zhang L; Chen C; Fu J; Lilley B; Berlinicke C; Hansen B; Ding D; Wang G; Wang T; Shou D; Ye Y; Mulligan T; Emmerich K; Saxena MT; Hall KR; Sharrock AV; Brandon C; Park H; Kam TI; Dawson VL; Dawson TM; Shim JS; Hanes J; Ji H; Liu JO; Qian J; Ackerley DF; Rohrer B; Zack DJ; Mumm JS
Elife; 2021 Jun; 10():. PubMed ID: 34184634
[TBL] [Abstract][Full Text] [Related]
4. Retinitis pigmentosa.
Hamel C
Orphanet J Rare Dis; 2006 Oct; 1():40. PubMed ID: 17032466
[TBL] [Abstract][Full Text] [Related]
5. AAV-Txnip prolongs cone survival and vision in mouse models of retinitis pigmentosa.
Xue Y; Wang SK; Rana P; West ER; Hong CM; Feng H; Wu DM; Cepko CL
Elife; 2021 Apr; 10():. PubMed ID: 33847261
[TBL] [Abstract][Full Text] [Related]
6. Long-term preservation of cone photoreceptors and visual acuity in rd10 mutant mice exposed to continuous environmental enrichment.
Barone I; Novelli E; Strettoi E
Mol Vis; 2014; 20():1545-56. PubMed ID: 25489227
[TBL] [Abstract][Full Text] [Related]
7. [Early therapeutic trials for retinitis pigmentosa].
Dufier JL
Bull Acad Natl Med; 2003; 187(9):1685-92; discussion 1692-4. PubMed ID: 15369238
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of Cone Degeneration in Retinitis Pigmentosa.
Song DJ; Bao XL; Fan B; Li GY
Cell Mol Neurobiol; 2023 Apr; 43(3):1037-1048. PubMed ID: 35792991
[TBL] [Abstract][Full Text] [Related]
9. [Retinitis pigmentosa - a review. Pathogenesis, guidelines for diagnostics and perspectives].
Zobor D; Zrenner E
Ophthalmologe; 2012 May; 109(5):501-14;quiz 515. PubMed ID: 22581051
[TBL] [Abstract][Full Text] [Related]
10. Antioxidants slow photoreceptor cell death in mouse models of retinitis pigmentosa.
Komeima K; Rogers BS; Campochiaro PA
J Cell Physiol; 2007 Dec; 213(3):809-15. PubMed ID: 17520694
[TBL] [Abstract][Full Text] [Related]
11. [Retinitis pigmentosa].
Bruninx R; Lepièce G
Rev Med Liege; 2020 Feb; 75(2):73-74. PubMed ID: 32030928
[TBL] [Abstract][Full Text] [Related]
12. ERG and other discriminators between advanced hydroxychloroquine retinopathy and retinitis pigmentosa.
Nair AA; Marmor MF
Doc Ophthalmol; 2017 Jun; 134(3):175-183. PubMed ID: 28451987
[TBL] [Abstract][Full Text] [Related]
13. Retinitis Pigmentosa: Current Clinical Management and Emerging Therapies.
Nguyen XT; Moekotte L; Plomp AS; Bergen AA; van Genderen MM; Boon CJF
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108642
[TBL] [Abstract][Full Text] [Related]
14. Cone rod dystrophies.
Hamel CP
Orphanet J Rare Dis; 2007 Feb; 2():7. PubMed ID: 17270046
[TBL] [Abstract][Full Text] [Related]
15. Rod- versus cone-driven ERGs at different stimulus sizes in normal subjects and retinitis pigmentosa patients.
Aher AJ; McKeefry DJ; Parry NRA; Maguire J; Murray IJ; Tsai TI; Huchzermeyer C; Kremers J
Doc Ophthalmol; 2018 Feb; 136(1):27-43. PubMed ID: 29134295
[TBL] [Abstract][Full Text] [Related]
16. Retinitis pigmentosa: defined from a molecular point of view.
van Soest S; Westerveld A; de Jong PT; Bleeker-Wagemakers EM; Bergen AA
Surv Ophthalmol; 1999; 43(4):321-34. PubMed ID: 10025514
[TBL] [Abstract][Full Text] [Related]
17. Inherited retinal degenerations: therapeutic prospects.
Delyfer MN; Léveillard T; Mohand-Saïd S; Hicks D; Picaud S; Sahel JA
Biol Cell; 2004 May; 96(4):261-9. PubMed ID: 15145530
[TBL] [Abstract][Full Text] [Related]
18. Retinitis Pigmentosa: Progress in Molecular Pathology and Biotherapeutical Strategies.
Liu W; Liu S; Li P; Yao K
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563274
[TBL] [Abstract][Full Text] [Related]
19. Reprogramming towards anabolism impedes degeneration in a preclinical model of retinitis pigmentosa.
Zhang L; Justus S; Xu Y; Pluchenik T; Hsu CW; Yang J; Duong JK; Lin CS; Jia Y; Bassuk AG; Mahajan VB; Tsang SH
Hum Mol Genet; 2016 Oct; 25(19):4244-4255. PubMed ID: 27516389
[TBL] [Abstract][Full Text] [Related]
20. Animal models and different therapies for treatment of retinitis pigmentosa.
Rivas MA; Vecino E
Histol Histopathol; 2009 Oct; 24(10):1295-322. PubMed ID: 19688697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
